Publication | Closed Access
Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection
182
Citations
23
References
2016
Year
Gilead Sciences.
| Year | Citations | |
|---|---|---|
Page 1
Page 1